Funding
Who raised, when, and from whom? Explore announced rounds, including emerging Indian companies, and company-reported SEC notices. Each amount keeps its original source and date.
1,460 filings · Form D notices of private raises, 2024-01-02 to 2026-03-31
Syncromune, Inc.Biotechnology
Fort Lauderdale, Florida · founded 2020 · Equity · 77 investors · Norman Schwartz, Eamonn Hobbs
Syncromune, Inc.Biotechnology
Fort Lauderdale, Florida · founded 2020 · Equity · 77 investors · Norman Schwartz, Eamonn Hobbs
Iantrek, Inc.Biotechnology
White Plains, New York · Equity · 21 investors · Tsontcho Ianchulev, Todd Sone
Gliknik IncBiotechnology
Baltimore, Maryland · Debt, Options, Convertible · 9 investors · David Block, Richard Levy
Medical 21, Inc.Biotechnology
Plymouth, Minnesota · Equity · 39 investors · Eric Solien, Erik Hermansen
Medical 21, Inc.Biotechnology
Plymouth, Minnesota · Equity · 39 investors · Eric Solien, Erik Hermansen
Decade, Inc.Biotechnology
Mountain View, California · founded 2024 · Equity, Series Seed Preferred Stock · 7 investors · Elliot Hershberg, Brian Naughton
Continuity Biosciences, LLCBiotechnology
Bradenton, Florida · founded 2023 · Equity · 13 investors · Michael Fowler, Allen Weiss
Rezo Therapeutics, Inc.Biotechnology
San Francisco, California · founded 2021 · Equity · 21 investors · Simeon George, Derek Hicks
Pattern Bioscience, Inc.Biotechnology
Austin, Texas · Equity · 6 investors · Junjun Gao, Scott Mendel
Entero Therapeutics, Inc.Biotechnology
St. Petersburg, Florida · Options, Convertible · 3 investors · Geordan Pursglove, Jason Sawyer
Elastro, Inc.Biotechnology
Watertown, Massachusetts · founded 2025 · Options · 6 investors · Michael Schrader, Ren Liu
SRT Therapeutics, Inc.Biotechnology
San Diego, California · founded 2024 · Equity · 55 investors · Rolf Benirschke, Brian Feagan, M.D.
ValCor Cath Inc.Biotechnology
Ottawa Hills, Ohio · founded 2023 · Equity · 52 investors · Howard Bobrow, Michael Bunker
ARTELO BIOSCIENCES, INC.Biotechnology
Solana Beach, California · Equity, Options, Convertible · 18 investors · Gregory Reyes, Connie Matsui
Qualigen Therapeutics, Inc.Biotechnology
Carlsbad, California · Equity, Convertible Preferred Stock can convert to underlying shares of Common · 14 investors · Robert Lim, Braeden Lichti
Kestrel Therapeutics Inc.Biotechnology
Boston, Massachusetts · founded 2020 · Debt, Options, Convertible · 6 investors · Nicholas Saccomano, Denis Patrick
Sower Solas I Sidecar III, LLCBiotechnology
Omaha, Nebraska · founded 2025 · Equity · 23 investors · Jared Hollinger
NovAb, Inc.Biotechnology
Tucker, Georgia · Debt, Convertible notes · 2 investors · Gregory Dane, Thomas Cannon
Axelyf, Inc.Biotechnology
Chestnut Hill, Massachusetts · founded 2025 · Equity · 37 investors · John Lucas, Arni Blondal
Rhinal Therapeutics Inc.Biotechnology
Las Vegas, Nevada · founded 2023 · Equity · 1 investors · Lawrence Fox, Mike George
Neuros Medical, Inc.Biotechnology
Aliso Viejo, California · Equity · 28 investors · David Veino, Joyce Erony
C2N JMK, Inc.Biotechnology
St. Louis, Missouri · founded 2025 · Debt · 2 investors · Jinzhu Yu
SAB Biotherapeutics, Inc.Biotechnology
Miami Beach, Florida · founded 2020 · Equity, Options · 17 investors · Andrew Moin, Jay Skyler
Celularity IncBiotechnology
Florham Park, New Jersey · Debt, Options, Convertible · 1 investors · Vincent LeVien, Robert Hariri
ProPhase Labs, Inc.Biotechnology
Uniondale, New York · Debt, Options · 2 investors · Louis Geckel, Warren Hirsch
Celularity IncBiotechnology
Florham Park, New Jersey · Equity, Options, Convertible · 1 investors · Robert Hariri, Stephen Brigido
Celularity IncBiotechnology
Florham Park, New Jersey · Equity, Options, Convertible · 14 investors · Peter Diamandis, Diane Parks
SpotitEarly, Inc.Biotechnology
Englewood, New Jersey · founded 2024 · Equity · 1 investors · Alon Lifshitz, Roi Ophir
Trevarx Biomedical, Inc.Biotechnology
Philadelphia, Pennsylvania · Debt, Options, Convertible · 6 investors · Jean Cho